QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.106.010819v1 34/10/1697    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sugamori, K. S. Articles by Grant, D. M. Search for Related Content PubMed PubMed Citation Articles by Sugamori, K. S. Articles by Grant, D. M.

In Vivo and in Vitro Metabolism of Arylamine Procarcinogens in Acetyltransferase-Deficient Mice

Department of Pharmacology, Faculty of Medicine (K.S.S., D.B., D.M.G.), and Leslie Dan Faculty of Pharmacy (D.M.G.), University of Toronto, Toronto, Ontario, Canada

Arylamine N-acetyltransferases (NATs) catalyze the biotransformation of a number of aromatic and heterocyclic amines, many of which are procarcinogenic agents. Interestingly, these enzymes are binary in nature, participating in both detoxification and activation reactions, and thus it is unclear what role NATs actually play in either preventing or enhancing toxic responses. The ultimate direction may be substrate-specific and dependent on its tissue-specific metabolism by competing, but genetically variable, drug-metabolizing enzymes. To investigate the effect of N-acetylation on the metabolism of some classical procarcinogenic arylamines, we have used our double knockout Nat1/2(–/–) mouse model to test both in vitro activity and the in vivo clearance of some of these agents. As expected, N-acetylation activity was undetectable in tissue cytosol preparations from Nat1/2(–/–) mice for 4-aminobiphenyl (ABP) and 2-aminofluorene (AF), whereas significant levels were measured in all wild-type tissue cytosols tested, indicating the widespread metabolism of these agents. Nat1/2(–/–) mice displayed a variable response with respect to in vivo pharmacokinetics. AF appeared to be most severely compromised, with a 3- to 4-fold increased area under the curve (AUC), whereas the clearance of ABP was found to be less dependent on N-acetylation, with no difference in ABP-AUC between wild-type and knockout animals. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine was neither N-acetylated nor was its clearance affected by NAT genotype, signifying a dependence on other drug-metabolizing enzymes. The elucidation of the role that N-acetylation plays in the clearance of procarcinogenic agents is the first step in attempting to correlate metabolism by NATs to toxic outcome prevention or augmentation.

This article has been cited by other articles:

				M. Martins, F. Rodrigues-Lima, J. Dairou, A. Lamouri, F. Malagnac, P. Silar, and J.-M. Dupret An Acetyltransferase Conferring Tolerance to Toxic Aromatic Amine Chemicals: MOLECULAR AND FUNCTIONAL STUDIES J. Biol. Chem., July 10, 2009; 284(28): 18726 - 18733. [Abstract] [Full Text] [PDF]

				D. W. Hein, J. Bendaly, J. R. Neale, and M. A. Doll Systemic Functional Expression of N-Acetyltransferase Polymorphism in the F344 Nat2 Congenic Rat Drug Metab. Dispos., December 1, 2008; 36(12): 2452 - 2459. [Abstract] [Full Text] [PDF]

				K. S. Sugamori, D. Brenneman, S. Wong, A. Gaedigk, V. Yu, H. Abramovici, R. Rozmahel, and D. M. Grant Effect of Arylamine Acetyltransferase Nat3 Gene Knockout on N-Acetylation in the Mouse Drug Metab. Dispos., July 1, 2007; 35(7): 1064 - 1070. [Abstract] [Full Text] [PDF]